Peloquin C A, Cumbo T J, Schentag J J
Department of Pharmaceutics, State University of New York, Buffalo.
Antimicrob Agents Chemother. 1991 Jun;35(6):1191-5. doi: 10.1128/AAC.35.6.1191.
We studied the effect of a single intravenous dose of tobramycin on the rate of bacterial eradication from urine in 10 patients with bladder catheters. The catheter was replaced 4 to 6 h after the tobramycin dose. Pseudomonas aeruginosa was found in 7 of the 10 patients, while members of the family Enterobacteriaceae accounted for the remaining pathogens. The MIC for each bacterium was determined in both broth and urine. Tobramycin eradicated the bacteria from eight patients. Bacteriuria resolved in 21.8 +/- 18.0 h, and urine bactericidal activity persisted for 43.4 +/- 20.3 h after the dose of tobramycin. Most patients were recolonized by another bacterial species if use of Foley catheters was resumed on a continuous basis. Two patients required additional doses of tobramycin to eradicate the original pathogen. There were significant temporal relationships between the pharmacokinetics of tobramycin and the change in colony count of bacteria in urine.
我们研究了单次静脉注射妥布霉素对10例膀胱置管患者尿液中细菌清除率的影响。在注射妥布霉素后4至6小时更换导管。10例患者中有7例检出铜绿假单胞菌,其余病原体为肠杆菌科成员。在肉汤和尿液中均测定了每种细菌的最低抑菌浓度(MIC)。妥布霉素使8例患者的细菌得以清除。用药后21.8±18.0小时菌尿消失,尿液杀菌活性在注射妥布霉素后持续43.4±20.3小时。如果持续使用弗利导管,大多数患者会被另一种细菌重新定植。两名患者需要额外剂量的妥布霉素来清除原始病原体。妥布霉素的药代动力学与尿液中细菌菌落计数的变化之间存在显著的时间关系。